Abstract：
In this review, we aimed to investigate the literature on sex-specific prevalence of meibomian gland dysfunction (MGD) and to determine whether women or men are more at risk for MGD.
A search was conducted on PubMed using the terms: (Sex OR Gender OR prevalence) AND (Meibomian gland).
Twenty-four relevant studies on MGD prevalence were identified, including 10 population-based and 14 hospital-based studies. Among the population-based studies, five studies reported higher rates among men, three studies found no differences, and one study observed higher rates among women. In the hospital-based studies, 10 studies reported no difference, two found higher rates among men, and one found higher among women. In the reviewed literature, there was a considerable variation between studies in terms of quality, sample size, age ranges, diagnostic criteria.
While most of the population-based studies suggest a higher prevalence among men, the majority of clinic-based studies show no significant difference. Further research with larger samples and standardized criteria is needed to determine whether men are indeed more susceptible to MGD.
A search was conducted on PubMed using the terms: (Sex OR Gender OR prevalence) AND (Meibomian gland).
Twenty-four relevant studies on MGD prevalence were identified, including 10 population-based and 14 hospital-based studies. Among the population-based studies, five studies reported higher rates among men, three studies found no differences, and one study observed higher rates among women. In the hospital-based studies, 10 studies reported no difference, two found higher rates among men, and one found higher among women. In the reviewed literature, there was a considerable variation between studies in terms of quality, sample size, age ranges, diagnostic criteria.
While most of the population-based studies suggest a higher prevalence among men, the majority of clinic-based studies show no significant difference. Further research with larger samples and standardized criteria is needed to determine whether men are indeed more susceptible to MGD.
摘要：
■在这篇评论中，我们的目的是调查性别特异性睑板腺功能障碍(MGD)患病率的文献,并确定女性还是男性患MGD的风险更大.
■在PubMed上使用以下术语进行搜索：（性别或性别或患病率）和（睑板腺）。
■确定了24项有关MGD患病率的相关研究，包括10项基于人群的研究和14项基于医院的研究。在基于人群的研究中，五项研究报告男性发病率较高，三项研究没有发现差异，一项研究观察到女性的发病率更高。在以医院为基础的研究中，10项研究报告没有差异，两个人在男性中发现了更高的比率，在女性中发现更高。在综述的文献中，在质量方面，研究之间存在相当大的差异，样本量,年龄范围,诊断标准。
虽然大多数基于人群的研究表明男性患病率较高，大多数基于临床的研究没有显着差异。需要进行更大样本和标准化标准的进一步研究，以确定男性是否确实更容易受到MGD的影响。
■在PubMed上使用以下术语进行搜索：（性别或性别或患病率）和（睑板腺）。
■确定了24项有关MGD患病率的相关研究，包括10项基于人群的研究和14项基于医院的研究。在基于人群的研究中，五项研究报告男性发病率较高，三项研究没有发现差异，一项研究观察到女性的发病率更高。在以医院为基础的研究中，10项研究报告没有差异，两个人在男性中发现了更高的比率，在女性中发现更高。在综述的文献中，在质量方面，研究之间存在相当大的差异，样本量,年龄范围,诊断标准。
虽然大多数基于人群的研究表明男性患病率较高，大多数基于临床的研究没有显着差异。需要进行更大样本和标准化标准的进一步研究，以确定男性是否确实更容易受到MGD的影响。
